SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported Non-GAAP net product sales of $1,245 million for the first quarter of 2012, a 17 percent increase from the same period in 2011. Non-GAAP net income for the first quarter of 2012 increased 23 percent to $484 million compared to $393 million in the first quarter of 2011. For the same periods, non-GAAP diluted earnings per share increased 30 percent to $1.08 from $0.83.